Literature DB >> 25104271

The combination of TP53INP1, TP53INP2 and AXIN2: potential biomarkers in papillary thyroid carcinoma.

Mengzi He1, Yinlong Zhao, Heqing Yi, Hui Sun, Xiaodong Liu, Shumei Ma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25104271     DOI： 10.1007/s12020-014-0341-8

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

1.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  Thyroid fine-needle aspiration: the relevance of BRAF mutation testing.

Authors:  Giuseppe Di Benedetto
Journal:  Endocrine       Date:  2014-03-04       Impact factor: 3.633

3.  Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?

Authors:  D Taïeb; S Giusiano; F Sebag; M Marcy; C de Micco; F F Palazzo; N J Dusetti; J L Iovanna; J F Henry; S Garcia; Colette Taranger-Charpin
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 4.  The epidemiology of thyroid disease and implications for screening.

Authors:  C Wang; L M Crapo
Journal:  Endocrinol Metab Clin North Am       Date:  1997-03       Impact factor: 4.741

Review 5.  Changing trends in thyroid practice: understanding nodular thyroid disease.

Authors:  Hossein Gharib
Journal:  Endocr Pract       Date:  2004 Jan-Feb       Impact factor: 3.443

6.  BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

Authors:  Anna Guerra; Vincenzo Marotta; Maurilio Deandrea; Manuela Motta; Paolo Piero Limone; Alessia Caleo; Pio Zeppa; Silvano Esposito; Franco Fulciniti; Mario Vitale
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

7.  Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Authors:  Nijaguna B Prasad; Helina Somervell; Ralph P Tufano; Alan P B Dackiw; Michael R Marohn; Joseph A Califano; Yongchun Wang; William H Westra; Douglas P Clark; Christopher B Umbricht; Steven K Libutti; Martha A Zeiger
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

8.  Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes.

Authors:  Takuya Shirakihara; Tomonori Kawasaki; Akihiko Fukagawa; Kentaro Semba; Ryuichi Sakai; Kohei Miyazono; Keiji Miyazawa; Masao Saitoh
Journal:  Cancer Sci       Date:  2013-07-20       Impact factor: 6.716

9.  Identification of a novel modulator of thyroid hormone receptor-mediated action.

Authors:  Bernhard G Baumgartner; Meritxell Orpinell; Jordi Duran; Vicent Ribas; Hans E Burghardt; Daniel Bach; Ana Victoria Villar; José C Paz; Meritxell González; Marta Camps; Josep Oriola; Francisca Rivera; Manuel Palacín; Antonio Zorzano
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

10.  Potential Urinary Protein Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients.

Authors:  Taha A Haj-Ahmad; Moemen Ak Abdalla; Yousef Haj-Ahmad
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207
View more
  5 in total

1.  Evaluation of the mRNA expression levels of integrins α3, α5, β1 and β6 as tumor biomarkers of oral squamous cell carcinoma.

Authors:  Hsueh-Wei Chang; Ching-Yu Yen; Chung-Ho Chen; Jun-Hsu Tsai; Jen-Yang Tang; Yung-Ting Chang; Yu-Hsun Kao; Yen-Yun Wang; Shyng-Shiou F Yuan; Sheng-Yang Lee
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

2.  An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma.

Authors:  Xuan Zhou; Ying-Zhi He; Dan Liu; Chao-Ran Lin; Dan Liang; Rui Huang; Liang Wang
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

3.  Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer.

Authors:  Esra Arslan; Tamer Aksoy; Taha Cumhan Şavlı; Didem Can Trabulus; Ahmet Volkan Sünter; Tevfik Fikret Çermik
Journal:  Mol Imaging Radionucl Ther       Date:  2022-06-27

4.  Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.

Authors:  Dan Cong; Mengzi He; Silin Chen; Xiaoli Liu; Xiaodong Liu; Hui Sun
Journal:  Onco Targets Ther       Date:  2015-08-26       Impact factor: 4.147

5.  MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma.

Authors:  Eman A Toraih; Afaf T Ibrahiem; Manal S Fawzy; Mohammad H Hussein; Saeed Awad M Al-Qahtani; Aly A M Shaalan
Journal:  Oxid Med Cell Longev       Date:  2017-09-20       Impact factor: 6.543
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.